本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mineralys Therapeutics, Inc.

27.56
-1.3500-4.67%
成交量:82.72萬
成交額:2,296.75萬
市值:24.30億
市盈率:-6.30
高:29.09
開:28.98
低:27.33
收:28.91
52周最高:47.65
52周最低:22.30
股本:8,815.85萬
流通股本:6,602.58萬
量比:0.59
換手率:1.25%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
淨資產收益率:-80.88%
總資產收益率:-46.18%
市淨率:4.41
市盈率(LYR):-12.03

資料載入中...

2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities